Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Taiwan · Delayed Price · Currency is TWD

133.00

-0.50 (-0.37%)

Aug 19, 2026, 9:05 AM CST

-30.73% (1Y)

Market Cap	11.31B -30.5%
Revenue (ttm)	4.27B +0.2%
Net Income	1.14B +28.9%
EPS	13.46 +28.9%
Shares Out	84.73M
PE Ratio	9.92
Forward PE	9.64
Dividend	7.75 (5.74%)
Ex-Dividend Date	Mar 26, 2026

Volume	2,000
Open	132.50
Previous Close	133.50
Day's Range	132.50 - 133.00
52-Week Range	122.00 - 190.00
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About TPEX:3218

Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides adminis... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1992

Employees 401

Stock Exchange Taipei Exchange

Ticker Symbol 3218

Full Company Profile

Financial Performance

In 2025, TPEX:3218's revenue was 4.20 billion, a decrease of -0.57% compared to the previous year's 4.23 billion. Earnings were 1.04 billion, a decrease of -2.07%.

Financial Statements